Bacteriotherapy for Clostridium difficile diarrhoea.

作者信息

Seal D V, Borriello S P, Piper M

出版信息

Lancet. 1989 Sep 2;2(8662):558. doi: 10.1016/s0140-6736(89)90674-0.

DOI:10.1016/s0140-6736(89)90674-0

PMID:2570250

Abstract

摘要

相似文献

Bacteriotherapy for Clostridium difficile diarrhoea.

Lancet. 1989 Sep 2;2(8662):558. doi: 10.1016/s0140-6736(89)90674-0.

Bacteriotherapy for chronic relapsing Clostridium difficile diarrhoea in six patients.

Lancet. 1989 May 27;1(8648):1156-60. doi: 10.1016/s0140-6736(89)92749-9.

Bacteriotherapy for Clostridium difficile diarrhoea.

Lancet. 1990 Jan 13;335(8681):110. doi: 10.1016/0140-6736(90)90574-o.

Rectal bacteriotherapy for recurrent Clostridium difficile-associated diarrhoea: results from a case series of 55 patients in Denmark 2000-2012.

Clin Microbiol Infect. 2015 Jan;21(1):48-53. doi: 10.1016/j.cmi.2014.07.003. Epub 2014 Oct 12.

Fecal bacteriotherapy, fecal transplant, and the microbiome.

J Clin Gastroenterol. 2010 Sep;44(8):529-30. doi: 10.1097/MCG.0b013e3181e1d6e2.

Fecal bacteriotherapy for recurrent Clostridium difficile infection.

Anaerobe. 2009 Dec;15(6):285-9. doi: 10.1016/j.anaerobe.2009.09.007. Epub 2009 Sep 22.

Fecal microbiota transplantation for the treatment of Clostridium difficile infection: a systematic review.

J Clin Gastroenterol. 2014 Sep;48(8):693-702. doi: 10.1097/MCG.0000000000000046.

[Fecal bacteriotherapy for the treatment of recurrent Clostridium difficile colitis used in the Clinic of Infectious Diseases of the University Hospital Brno in 2010-2014 - a prospective study].

Epidemiol Mikrobiol Imunol. 2015 Oct;64(4):232-5.

Fecal microbiota transplantation for treatment of Clostridium difficile infection.

J Clin Gastroenterol. 2015 Feb;49(2):171-2. doi: 10.1097/MCG.0000000000000189.

[Infectious Clostridium difficile diarrhea].

Union Med Can. 1984 Dec;113(12):1026-8.

引用本文的文献

Fecal Microbiota Transplantation: Indications, Methods, and Challenges.

J Microbiol. 2024 Dec;62(12):1057-1074. doi: 10.1007/s12275-024-00184-3. Epub 2024 Nov 18.

Synthetic consortia of nanobody-coupled and formatted bacteria for prophylaxis and therapy interventions targeting microbiome dysbiosis-associated diseases and co-morbidities.

Microb Biotechnol. 2019 Jan;12(1):58-65. doi: 10.1111/1751-7915.13355.

Fame and future of faecal transplantations--developing next-generation therapies with synthetic microbiomes.

Microb Biotechnol. 2013 Jul;6(4):316-25. doi: 10.1111/1751-7915.12047. Epub 2013 Apr 10.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验